SlideShare a Scribd company logo
1 of 17
Download to read offline
PATENT LAW FOR EMERGING TECHNOLOGIES
THE EFFECT OF ABSTRACT EXAMPLES IN BIOTECH
Roy P. Issac, Ph. D., J. D.
AIPLA Biotechnology Committee Webinar
21 April, 2015
.
PATENT LAW FOR EMERGING TECHNOLOGIES
This presentation is intended for educational
purposes only. It is not intended to convey legal
advice pertaining to any particular situation and is
not a substitute for legal advice.
20
PATENT LAW FOR EMERGING TECHNOLOGIES
Issues to consider for claims involving
abstract ideas or laws of nature
When is the use of the abstract idea or law nature analysis
necessary?
The rule from the recent Supreme Court cases has been used since
O’Reilly v. Morse (1854) and Nielson v. Harford (1841). Has the
recent cases changed the application of this rule?
Are the recent cases providing a rationale for the increased use of
abstract ideas/ law of nature analysis?
Should the abstract idea/ law of nature analysis be limited to cases
where the claims wholly preempt the application of the law of nature
or abstract idea in all fields?
21
PATENT LAW FOR EMERGING TECHNOLOGIES
Recent Supreme Court Cases Addressing Patent Eligibility
of Claims Involving Abstract Ideas/ Laws of Nature
 Bilski v. Kappos
 Mayo v. Prometheus
 Alice v. CLS Bank
 The abstract idea or laws of nature analysis is applied when
the claim purports to entirely preempt the application of the
law of nature or abstract idea.
 These cases follow dissection analysis of claims rather than
considering the claim as a whole.
– Dissect out the abstract idea of law of nature and analyze
what is left for an inventive concept.
 Preemption is a focus in all three cases.
22
PATENT LAW FOR EMERGING TECHNOLOGIES
Is the claim directed to an abstract idea?
i. A method of organizing human activity
ii. An idea itself
iii. A mathematical relationship
iv. Fundamental economic practice
Determine whether an element in the claim directed to a law of nature
or abstract idea will tie-up the subject matter and pre-empt others
from using the judicial exception.
Do the patent claims add enough to their statements of abstract ideas
or laws of nature to allow the processes they describe to qualify as
patent-eligible processes that apply natural laws?
23
PATENT LAW FOR EMERGING TECHNOLOGIES
Does any element, or combination of elements, in the claim sufficient to
ensure that the claim amounts to significantly more than the judicial
exception?
Here the claim elements are analyzed by dissecting the judicial
exception out of the claim and determining if the additional elements
add sufficiently more.
Inventive concept: Does the claim as a whole amount to significantly
more than the exception itself?
– Claim is analyzed as a whole.
– Individual elements viewed on their own may not appear to add
significantly more to the claim, but when combined may amount to
significantly more than the exception.
24
PATENT LAW FOR EMERGING TECHNOLOGIES
Bilski v. Kappos
Method of hedging
Dissect out abstract idea or law of nature from the claim and
consider as it is in the prior art and analyze the rest of the claims to
see if the elements alone or in combination amounts something
more than conventional or routine activity.
Follows Parker v. Flook (1978), O’Reilly v. Morse (1854) and
Neilson v. Harford (1841, English case)
25
PATENT LAW FOR EMERGING TECHNOLOGIES
“[I]t is clear that petitioners’ application is not a patentable
“process.” Claims 1 and 4 in petitioners’ application explain
the basic concept of hedging, or protecting against risk.”
“The concept of hedging, described in claim 1 and reduced to
a mathematical formula in claim 4, is an unpatentable
abstract idea, just like the algorithms at issue in Benson and
Flook.”
“Allowing petitioners to patent risk hedging would preempt
use of this approach in all fields, and would effectively grant a
monopoly over an abstract idea.”
Court’s Analysis
26
PATENT LAW FOR EMERGING TECHNOLOGIES
Mayo v. Prometheus
 Patent application directed to adjusting dosing regimen based on a
precise correlation between metabolite levels and likelihood for side
effects.
– A method of optimizing therapeutic efficacy …..comprising:
(a) administering a drug providing 6-thioguanine to a subject having said
immune-mediated gastrointestinal disorder; and
(b) determining the level of 6-thioguanine in said subject having said immune-
mediated gastrointestinal disorder,
wherein the level of 6-thioguanine less than …. indicates a need to increase the
amount of said drug subsequently administered to said subject
the level of 6-thioguanine greater than….indicates a need to decrease the amount
of said drug subsequently administered to said subject.
27
PATENT LAW FOR EMERGING TECHNOLOGIES
Law of nature
Correlations between thiopurine metabolite levels and the toxicity
and efficacy of the thiopurine drug dosage.
The administering step, determining step and the wherein clause are
not themselves natural laws. However, they failed to transform the
nature of the claim.
The administering step simply refers to the relevant audience, i.e.,
doctors who treat patients with certain diseases with thiopurine drugs.
Prohibition against patenting abstract ideas cannot be
circumvented by attempting to limit the use of the formula to the
relevant audience.
Court’s Analysis
28
PATENT LAW FOR EMERGING TECHNOLOGIES
“Beyond picking out the relevant audience, namely those who
administer doses of thiopurine drugs, the claim simply tells
doctors to: (1) measure (somehow) the current level of the relevant
metabolite, (2) use particular (unpatentable) laws of nature (which
the claim set forth) to calculate the current toxicity/inefficacy
limits, and (3) reconsider the drug dosage in light of the law [of
nature].”
In the Court’s view the claim amounted to merely stating the law of
nature and asking the doctors to apply it.
Court’s Analysis
29
PATENT LAW FOR EMERGING TECHNOLOGIES
 Has the claimed process transformed unpatentable natural
laws into patent eligible applications of those laws?
 Is there an “inventive concept?”
 Are the steps in the claimed processes (apart from the
natural laws themselves) involve well-understood, routine,
conventional activity previously engaged in by researchers
in the field?
 Adding insignificant post-solution activity is said to be not
sufficient.
30
PATENT LAW FOR EMERGING TECHNOLOGIES
Alice v. CLS Bank
Claims directed to the use of computers for the intermediate settlement of
banking transactions.
Computer acts as the third party intermediary for mitigating the
settlement risk that one of the parties to a transaction will not satisfy
his obligations.
Two-step analysis:
First determine whether the claims at issue are directed to a patent-
ineligible concept. Intermediate settlement, like hedging (Bilski) was
deemed an abstract idea.
Secondly, examine the elements of the claim to determine whether it
contains an “‘inventive concept’” sufficient to “transform” the claimed
abstract idea into a patent-eligible application.
31
PATENT LAW FOR EMERGING TECHNOLOGIES
• Abstract ideas are not limited to claims involving
mathematical formulas.
• Hedging in Bilski and intermediated settlement are
“squarely within the realm of abstract ideas.”
• The Court “need not labor to delimit the precise
contours of the “abstract ideas” category in this case.
Court’s Analysis
32
PATENT LAW FOR EMERGING TECHNOLOGIES
Take home points
 Determine whether the claim is directed to abstract idea or law
of nature
 Determine whether the claim preempts all uses of the abstract
idea or law of nature.
 Determine when to analyze the claim as a whole and when to
focus on the nature-based product element.
33
PATENT LAW FOR EMERGING TECHNOLOGIES
Let’s not forget
 Too broad an interpretation of this exclusionary principle could eviscerate patent
law. (Mayo v. Prometheus)
 All inventions at some level embody, use, reflect, rest upon, or apply laws of
nature, natural phenomena, or abstract ideas.
 A process is not unpatentable simply because it contains a law of nature or a
mathematical algorithm. (Parker v. Flook)
 An application of a law of nature or mathematical formula to a known structure
or process may well be deserving of patent protection. (Diamond v. Diehr)
 While a scientific truth, or the mathematical expression of it, is not a patentable
invention, a novel and useful structure created with the aid of knowledge of
scientific truth may be. (Mackay Radio)
 At the same time, we tread carefully in construing this exclusionary principle lest
it swallow all of patent law. (Alice)
34
PATENT LAW FOR EMERGING TECHNOLOGIES
Thank you!
Questions?
Elmore Patent Law Group, P.C.
484 Groton Rd.
Westford, MA 01886
978.251.3501
rissac@elmorepatents.com
35

More Related Content

Viewers also liked

Homework of languaje arts
Homework of languaje artsHomework of languaje arts
Homework of languaje artsnerio12
 
Políticas de integración y salud de inmigrantes en Europa: tres estudios comp...
Políticas de integración y salud de inmigrantes en Europa: tres estudios comp...Políticas de integración y salud de inmigrantes en Europa: tres estudios comp...
Políticas de integración y salud de inmigrantes en Europa: tres estudios comp...sophieproject
 
Responsive galleries
Responsive galleriesResponsive galleries
Responsive galleriesIsabel Brison
 
從珠寶看個性
從珠寶看個性從珠寶看個性
從珠寶看個性neo423
 
Girls on the Run PR Campaign doc
Girls on the Run PR Campaign docGirls on the Run PR Campaign doc
Girls on the Run PR Campaign docChandler Wicke
 
Bogor sales target
Bogor sales targetBogor sales target
Bogor sales targetteguh319666
 
Numberwise Info Guide
Numberwise Info GuideNumberwise Info Guide
Numberwise Info GuideGreg Swart
 

Viewers also liked (13)

Homework of languaje arts
Homework of languaje artsHomework of languaje arts
Homework of languaje arts
 
Project management week 3
Project management week 3Project management week 3
Project management week 3
 
Políticas de integración y salud de inmigrantes en Europa: tres estudios comp...
Políticas de integración y salud de inmigrantes en Europa: tres estudios comp...Políticas de integración y salud de inmigrantes en Europa: tres estudios comp...
Políticas de integración y salud de inmigrantes en Europa: tres estudios comp...
 
reALIGN methodologies, case studies
reALIGN methodologies, case studiesreALIGN methodologies, case studies
reALIGN methodologies, case studies
 
Responsive galleries
Responsive galleriesResponsive galleries
Responsive galleries
 
從珠寶看個性
從珠寶看個性從珠寶看個性
從珠寶看個性
 
Girls on the Run PR Campaign doc
Girls on the Run PR Campaign docGirls on the Run PR Campaign doc
Girls on the Run PR Campaign doc
 
VBV_presentation_revidert_LOW
VBV_presentation_revidert_LOWVBV_presentation_revidert_LOW
VBV_presentation_revidert_LOW
 
Bogor sales target
Bogor sales targetBogor sales target
Bogor sales target
 
Numberwise Info Guide
Numberwise Info GuideNumberwise Info Guide
Numberwise Info Guide
 
RecommendationLinkedin
RecommendationLinkedinRecommendationLinkedin
RecommendationLinkedin
 
Redmint f163
Redmint f163Redmint f163
Redmint f163
 
Resume June 2015
Resume June 2015Resume June 2015
Resume June 2015
 

Similar to 4 21 15 FINAL Slides

Issues in U.S. Biotech and Pharma Patenting: Patentable Subject Matter: and t...
Issues in U.S. Biotech and Pharma Patenting: Patentable Subject Matter: and t...Issues in U.S. Biotech and Pharma Patenting: Patentable Subject Matter: and t...
Issues in U.S. Biotech and Pharma Patenting: Patentable Subject Matter: and t...Patterson Thuente IP
 
Biotech patents after_prometheus_les
Biotech patents after_prometheus_lesBiotech patents after_prometheus_les
Biotech patents after_prometheus_lesdbania
 
Subject Matter Patent Eligibility, 2015, Rodney Sparks
Subject Matter Patent Eligibility, 2015, Rodney SparksSubject Matter Patent Eligibility, 2015, Rodney Sparks
Subject Matter Patent Eligibility, 2015, Rodney SparksRodney Sparks
 
Stronger Life Science Patents (MichBio)
Stronger Life Science Patents (MichBio)Stronger Life Science Patents (MichBio)
Stronger Life Science Patents (MichBio)Aurora Consulting
 
Hallenbeck Post-Alice Claiming and Prosecution
Hallenbeck Post-Alice Claiming and ProsecutionHallenbeck Post-Alice Claiming and Prosecution
Hallenbeck Post-Alice Claiming and Prosecutionjimhallenbeck
 
protection of product and design innovations
protection of product and design innovationsprotection of product and design innovations
protection of product and design innovationswelcometofacebook
 
Intellectual property rights (2)
Intellectual property rights (2)Intellectual property rights (2)
Intellectual property rights (2)9033955713
 
Doctrine of equivalants
Doctrine of equivalantsDoctrine of equivalants
Doctrine of equivalantsAltacit Global
 
Patentability of Diagnostic Inventions
Patentability of Diagnostic InventionsPatentability of Diagnostic Inventions
Patentability of Diagnostic InventionsMarcus A. Streips
 
Biotech Patentable Subject Matter After Bilski
Biotech Patentable Subject Matter After BilskiBiotech Patentable Subject Matter After Bilski
Biotech Patentable Subject Matter After Bilskiwardjohn1346
 
pharmacoepidemiology individual assignment..pptx
pharmacoepidemiology individual assignment..pptxpharmacoepidemiology individual assignment..pptx
pharmacoepidemiology individual assignment..pptxMastewal7
 
Indian Patent act, 20 feb
Indian Patent act, 20 febIndian Patent act, 20 feb
Indian Patent act, 20 febjyothics
 
Sec 3 (c) of the patent act 1970
Sec 3 (c) of the patent act 1970Sec 3 (c) of the patent act 1970
Sec 3 (c) of the patent act 1970Harshal Bhale
 
USPTO Examiner Guidelines Post - Alice v. CLS Bank
USPTO Examiner Guidelines Post - Alice v. CLS BankUSPTO Examiner Guidelines Post - Alice v. CLS Bank
USPTO Examiner Guidelines Post - Alice v. CLS BankUSPatentsNMore
 
Non patentable inventions in india
Non patentable inventions in indiaNon patentable inventions in india
Non patentable inventions in indiaatuljaybhaye
 
Guatemalan Pharmaceuticals
Guatemalan PharmaceuticalsGuatemalan Pharmaceuticals
Guatemalan PharmaceuticalsJenny Mancini
 
nnano 2007 55 From the lab to the market
nnano 2007 55 From the lab to the marketnnano 2007 55 From the lab to the market
nnano 2007 55 From the lab to the marketMike Helmus
 

Similar to 4 21 15 FINAL Slides (20)

Issues in U.S. Biotech and Pharma Patenting: Patentable Subject Matter: and t...
Issues in U.S. Biotech and Pharma Patenting: Patentable Subject Matter: and t...Issues in U.S. Biotech and Pharma Patenting: Patentable Subject Matter: and t...
Issues in U.S. Biotech and Pharma Patenting: Patentable Subject Matter: and t...
 
Biotech patents after_prometheus_les
Biotech patents after_prometheus_lesBiotech patents after_prometheus_les
Biotech patents after_prometheus_les
 
Subject Matter Patent Eligibility, 2015, Rodney Sparks
Subject Matter Patent Eligibility, 2015, Rodney SparksSubject Matter Patent Eligibility, 2015, Rodney Sparks
Subject Matter Patent Eligibility, 2015, Rodney Sparks
 
Feb Biocom panel
Feb Biocom panelFeb Biocom panel
Feb Biocom panel
 
Stronger Life Science Patents (MichBio)
Stronger Life Science Patents (MichBio)Stronger Life Science Patents (MichBio)
Stronger Life Science Patents (MichBio)
 
Hallenbeck Post-Alice Claiming and Prosecution
Hallenbeck Post-Alice Claiming and ProsecutionHallenbeck Post-Alice Claiming and Prosecution
Hallenbeck Post-Alice Claiming and Prosecution
 
protection of product and design innovations
protection of product and design innovationsprotection of product and design innovations
protection of product and design innovations
 
Intellectual property rights (2)
Intellectual property rights (2)Intellectual property rights (2)
Intellectual property rights (2)
 
Doctrine of equivalants
Doctrine of equivalantsDoctrine of equivalants
Doctrine of equivalants
 
Patentability of Diagnostic Inventions
Patentability of Diagnostic InventionsPatentability of Diagnostic Inventions
Patentability of Diagnostic Inventions
 
Biotech Patentable Subject Matter After Bilski
Biotech Patentable Subject Matter After BilskiBiotech Patentable Subject Matter After Bilski
Biotech Patentable Subject Matter After Bilski
 
pharmacoepidemiology individual assignment..pptx
pharmacoepidemiology individual assignment..pptxpharmacoepidemiology individual assignment..pptx
pharmacoepidemiology individual assignment..pptx
 
Indian Patent act, 20 feb
Indian Patent act, 20 febIndian Patent act, 20 feb
Indian Patent act, 20 feb
 
Sec 3 (c) of the patent act 1970
Sec 3 (c) of the patent act 1970Sec 3 (c) of the patent act 1970
Sec 3 (c) of the patent act 1970
 
USPTO Examiner Guidelines Post - Alice v. CLS Bank
USPTO Examiner Guidelines Post - Alice v. CLS BankUSPTO Examiner Guidelines Post - Alice v. CLS Bank
USPTO Examiner Guidelines Post - Alice v. CLS Bank
 
ACC_SF_PA
ACC_SF_PAACC_SF_PA
ACC_SF_PA
 
Non patentable inventions in india
Non patentable inventions in indiaNon patentable inventions in india
Non patentable inventions in india
 
04-Patentable Subject Matter 35 USC §101
04-Patentable Subject Matter 35 USC §10104-Patentable Subject Matter 35 USC §101
04-Patentable Subject Matter 35 USC §101
 
Guatemalan Pharmaceuticals
Guatemalan PharmaceuticalsGuatemalan Pharmaceuticals
Guatemalan Pharmaceuticals
 
nnano 2007 55 From the lab to the market
nnano 2007 55 From the lab to the marketnnano 2007 55 From the lab to the market
nnano 2007 55 From the lab to the market
 

4 21 15 FINAL Slides

  • 1. PATENT LAW FOR EMERGING TECHNOLOGIES THE EFFECT OF ABSTRACT EXAMPLES IN BIOTECH Roy P. Issac, Ph. D., J. D. AIPLA Biotechnology Committee Webinar 21 April, 2015 .
  • 2. PATENT LAW FOR EMERGING TECHNOLOGIES This presentation is intended for educational purposes only. It is not intended to convey legal advice pertaining to any particular situation and is not a substitute for legal advice. 20
  • 3. PATENT LAW FOR EMERGING TECHNOLOGIES Issues to consider for claims involving abstract ideas or laws of nature When is the use of the abstract idea or law nature analysis necessary? The rule from the recent Supreme Court cases has been used since O’Reilly v. Morse (1854) and Nielson v. Harford (1841). Has the recent cases changed the application of this rule? Are the recent cases providing a rationale for the increased use of abstract ideas/ law of nature analysis? Should the abstract idea/ law of nature analysis be limited to cases where the claims wholly preempt the application of the law of nature or abstract idea in all fields? 21
  • 4. PATENT LAW FOR EMERGING TECHNOLOGIES Recent Supreme Court Cases Addressing Patent Eligibility of Claims Involving Abstract Ideas/ Laws of Nature  Bilski v. Kappos  Mayo v. Prometheus  Alice v. CLS Bank  The abstract idea or laws of nature analysis is applied when the claim purports to entirely preempt the application of the law of nature or abstract idea.  These cases follow dissection analysis of claims rather than considering the claim as a whole. – Dissect out the abstract idea of law of nature and analyze what is left for an inventive concept.  Preemption is a focus in all three cases. 22
  • 5. PATENT LAW FOR EMERGING TECHNOLOGIES Is the claim directed to an abstract idea? i. A method of organizing human activity ii. An idea itself iii. A mathematical relationship iv. Fundamental economic practice Determine whether an element in the claim directed to a law of nature or abstract idea will tie-up the subject matter and pre-empt others from using the judicial exception. Do the patent claims add enough to their statements of abstract ideas or laws of nature to allow the processes they describe to qualify as patent-eligible processes that apply natural laws? 23
  • 6. PATENT LAW FOR EMERGING TECHNOLOGIES Does any element, or combination of elements, in the claim sufficient to ensure that the claim amounts to significantly more than the judicial exception? Here the claim elements are analyzed by dissecting the judicial exception out of the claim and determining if the additional elements add sufficiently more. Inventive concept: Does the claim as a whole amount to significantly more than the exception itself? – Claim is analyzed as a whole. – Individual elements viewed on their own may not appear to add significantly more to the claim, but when combined may amount to significantly more than the exception. 24
  • 7. PATENT LAW FOR EMERGING TECHNOLOGIES Bilski v. Kappos Method of hedging Dissect out abstract idea or law of nature from the claim and consider as it is in the prior art and analyze the rest of the claims to see if the elements alone or in combination amounts something more than conventional or routine activity. Follows Parker v. Flook (1978), O’Reilly v. Morse (1854) and Neilson v. Harford (1841, English case) 25
  • 8. PATENT LAW FOR EMERGING TECHNOLOGIES “[I]t is clear that petitioners’ application is not a patentable “process.” Claims 1 and 4 in petitioners’ application explain the basic concept of hedging, or protecting against risk.” “The concept of hedging, described in claim 1 and reduced to a mathematical formula in claim 4, is an unpatentable abstract idea, just like the algorithms at issue in Benson and Flook.” “Allowing petitioners to patent risk hedging would preempt use of this approach in all fields, and would effectively grant a monopoly over an abstract idea.” Court’s Analysis 26
  • 9. PATENT LAW FOR EMERGING TECHNOLOGIES Mayo v. Prometheus  Patent application directed to adjusting dosing regimen based on a precise correlation between metabolite levels and likelihood for side effects. – A method of optimizing therapeutic efficacy …..comprising: (a) administering a drug providing 6-thioguanine to a subject having said immune-mediated gastrointestinal disorder; and (b) determining the level of 6-thioguanine in said subject having said immune- mediated gastrointestinal disorder, wherein the level of 6-thioguanine less than …. indicates a need to increase the amount of said drug subsequently administered to said subject the level of 6-thioguanine greater than….indicates a need to decrease the amount of said drug subsequently administered to said subject. 27
  • 10. PATENT LAW FOR EMERGING TECHNOLOGIES Law of nature Correlations between thiopurine metabolite levels and the toxicity and efficacy of the thiopurine drug dosage. The administering step, determining step and the wherein clause are not themselves natural laws. However, they failed to transform the nature of the claim. The administering step simply refers to the relevant audience, i.e., doctors who treat patients with certain diseases with thiopurine drugs. Prohibition against patenting abstract ideas cannot be circumvented by attempting to limit the use of the formula to the relevant audience. Court’s Analysis 28
  • 11. PATENT LAW FOR EMERGING TECHNOLOGIES “Beyond picking out the relevant audience, namely those who administer doses of thiopurine drugs, the claim simply tells doctors to: (1) measure (somehow) the current level of the relevant metabolite, (2) use particular (unpatentable) laws of nature (which the claim set forth) to calculate the current toxicity/inefficacy limits, and (3) reconsider the drug dosage in light of the law [of nature].” In the Court’s view the claim amounted to merely stating the law of nature and asking the doctors to apply it. Court’s Analysis 29
  • 12. PATENT LAW FOR EMERGING TECHNOLOGIES  Has the claimed process transformed unpatentable natural laws into patent eligible applications of those laws?  Is there an “inventive concept?”  Are the steps in the claimed processes (apart from the natural laws themselves) involve well-understood, routine, conventional activity previously engaged in by researchers in the field?  Adding insignificant post-solution activity is said to be not sufficient. 30
  • 13. PATENT LAW FOR EMERGING TECHNOLOGIES Alice v. CLS Bank Claims directed to the use of computers for the intermediate settlement of banking transactions. Computer acts as the third party intermediary for mitigating the settlement risk that one of the parties to a transaction will not satisfy his obligations. Two-step analysis: First determine whether the claims at issue are directed to a patent- ineligible concept. Intermediate settlement, like hedging (Bilski) was deemed an abstract idea. Secondly, examine the elements of the claim to determine whether it contains an “‘inventive concept’” sufficient to “transform” the claimed abstract idea into a patent-eligible application. 31
  • 14. PATENT LAW FOR EMERGING TECHNOLOGIES • Abstract ideas are not limited to claims involving mathematical formulas. • Hedging in Bilski and intermediated settlement are “squarely within the realm of abstract ideas.” • The Court “need not labor to delimit the precise contours of the “abstract ideas” category in this case. Court’s Analysis 32
  • 15. PATENT LAW FOR EMERGING TECHNOLOGIES Take home points  Determine whether the claim is directed to abstract idea or law of nature  Determine whether the claim preempts all uses of the abstract idea or law of nature.  Determine when to analyze the claim as a whole and when to focus on the nature-based product element. 33
  • 16. PATENT LAW FOR EMERGING TECHNOLOGIES Let’s not forget  Too broad an interpretation of this exclusionary principle could eviscerate patent law. (Mayo v. Prometheus)  All inventions at some level embody, use, reflect, rest upon, or apply laws of nature, natural phenomena, or abstract ideas.  A process is not unpatentable simply because it contains a law of nature or a mathematical algorithm. (Parker v. Flook)  An application of a law of nature or mathematical formula to a known structure or process may well be deserving of patent protection. (Diamond v. Diehr)  While a scientific truth, or the mathematical expression of it, is not a patentable invention, a novel and useful structure created with the aid of knowledge of scientific truth may be. (Mackay Radio)  At the same time, we tread carefully in construing this exclusionary principle lest it swallow all of patent law. (Alice) 34
  • 17. PATENT LAW FOR EMERGING TECHNOLOGIES Thank you! Questions? Elmore Patent Law Group, P.C. 484 Groton Rd. Westford, MA 01886 978.251.3501 rissac@elmorepatents.com 35